[HTML][HTML] Dysphagia management during COVID-19 pandemic: A review of the literature and international guidelines
S Eyigör, E Umay - Turkish journal of physical medicine and …, 2021 - ncbi.nlm.nih.gov
In this review, we present the safest and most effective diagnosis and treatment approaches
to dysphagia during the novel coronavirus-2019 (COVID-19) pandemic in the light of …
to dysphagia during the novel coronavirus-2019 (COVID-19) pandemic in the light of …
[HTML][HTML] Safety and Outcome of High-Flow Nasal Oxygen Therapy Outside ICU Setting in Hypoxemic Patients With COVID-19
ML Janssen, Y Türk, SJ Baart, W Hanselaar… - Critical Care …, 2024 - journals.lww.com
OBJECTIVE: High-flow nasal oxygen (HFNO) therapy is frequently applied outside ICU
setting in hypoxemic patients with COVID-19. However, safety concerns limit more …
setting in hypoxemic patients with COVID-19. However, safety concerns limit more …
Non-invasive oxygenation strategies for respiratory failure with COVID-19: a concise narrative review of literature in pre and mid-COVID-19 era
K Ogawa, K Asano, J Ikeda, T Fujii - Anaesthesia Critical Care & Pain …, 2021 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) has spread globally and can cause a
shortage of medical resources, in particular, mechanical ventilators. High-flow nasal cannula …
shortage of medical resources, in particular, mechanical ventilators. High-flow nasal cannula …
Outcomes and characteristics of COVID-19 patients treated with continuous positive airway pressure/high-flow nasal oxygen outside the intensive care setting
Background Continuous positive airway pressure (CPAP) and high-flow nasal oxygen
(HFNO) have been used to manage hypoxaemic respiratory failure secondary to …
(HFNO) have been used to manage hypoxaemic respiratory failure secondary to …
[HTML][HTML] High-flow nasal oxygen (HFNO) for patients with Covid-19 outside intensive care units
I Issa, M Söderberg - Respiratory Medicine, 2021 - Elsevier
Introduction High-flow nasal oxygen (HFNO) has traditionally only been used in intensive
care units (ICU) especially in acute respiratory distress syndrome (ARDS). Methods We …
care units (ICU) especially in acute respiratory distress syndrome (ARDS). Methods We …
[HTML][HTML] High-flow oxygen therapy in elderly patients infected with SARS-CoV2 with a contraindication for transfer to an intensive care unit: a preliminary report
JC Lagier, S Amrane, M Mailhe, M Gainnier… - International Journal of …, 2021 - Elsevier
Objectives In a conventional hospital ward, we used high-flow nasal oxygen (HFNO) to treat
elderly COVID-19 patients noneligible for intensive care unit transfer. Methods This study …
elderly COVID-19 patients noneligible for intensive care unit transfer. Methods This study …
[PDF][PDF] High-flow nasal oxygen therapy in the treatment of acute respiratory failure in severe COVID-19 pneumonia: a prospective observational study
N Celejewska-Wojcik, K Polok, K Gorka… - Pol Arch Intern …, 2021 - scholar.archive.org
Introduction: A significant proportion of patients with COVID-19 present with a rapidly
progressing severe acute respiratory failure (ARF). Objectives: We aimed to assess the …
progressing severe acute respiratory failure (ARF). Objectives: We aimed to assess the …
[HTML][HTML] Airborne particle dispersion by high flow nasal oxygen: An experimental and CFD analysis
High Flow Nasal Oxygen (HFNO) therapy offers a proven means of delivering respiratory
support to critically ill patients suffering from viral illness such as COVID-19. However, the …
support to critically ill patients suffering from viral illness such as COVID-19. However, the …
A COVID-19 field hospital in a conference centre–The Cape Town, South Africa experience
B Bulajic, K Ekambaram, C Saunders… - African Journal of …, 2021 - journals.co.za
Background The coronavirus pandemic has put extreme pressure on health care services in
South Africa. Aim To describe the design, patients and outcomes of a field hospital during …
South Africa. Aim To describe the design, patients and outcomes of a field hospital during …
[HTML][HTML] A randomised controlled trial of high-flow nasal oxygen versus non-rebreathing oxygen face mask therapy in acute hypoxaemic respiratory failure
B Thota, A Samantaray, B Vengamma… - Indian Journal of …, 2022 - journals.lww.com
Methods: In this prospective open labelled study, 122 COVID-19 patients presenting with
acute hypoxaemic respiratory failure (AHRF) were randomised to receive either HFNO or …
acute hypoxaemic respiratory failure (AHRF) were randomised to receive either HFNO or …